reference/26456814

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/26456814

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, Non-U.S. Gov't
endingPage	1544
issn	2373-8227
issueIdentifier	6
pageRange	1535-1544
publicationName	ACS Infectious Diseases
startingPage	1535
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_e0e9009f94a729fa9c6361d78a1a86c1 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_6e6a1576e1dd63880dbb1cc636c5850b http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_c04fd0c1eda847c5e722e761bd859dc8 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_d8bf1b8a20fd2206046febe5b38ecb1a http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_6ea5a40f4bbc04a8349c1ce21f6d6855 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_8c0597bf9bd1d207d1af38e43a829c7a http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_6451a78908fd3ad66ad87935cb87805c
bibliographicCitation	Zhao J, Zhang Y, Wang M, Liu Q, Lei X, Wu M, Guo S, Yi D, Li Q, Ma L, Liu Z, Guo F, Wang J, Li X, Wang Y, Cen S. Quinoline and Quinazoline Derivatives Inhibit Viral RNA Synthesis by SARS-CoV-2 RdRp. ACS Infect Dis. 2021 Jun 11;7(6):1535–44. doi: 10.1021/acsinfecdis.1c00083. PMID: 34038639.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_503b0c03e69a6a0e9c37341f33bd9194 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_554053cfcf288438a7babdb1970bca40 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ed186ddbc797326e520bf65de551a653 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_55f6ca308ca766ba4e0c34f55f517671 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f07a2ac03eecbedb3647fbe3eda050e3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5c5b1bdd07dd9ad0f228dbfae83709fb http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_97ae43c1e5422b70b0d9ebdec1c8291d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ce2fc81231429f37a27999fdf369113f http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-3358-0411 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a9a52730d4e95253c318c7922249be9a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cecaa9326b487cabc8d86e3c37f479e2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cdca98623435a7d7b3fe7c3c31b595d6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5736fa8200c184818fb5e11e10f6baa2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_02cf680eb21f9326f8abf9d307afa970 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fdd85219260ef55dd9075739231bb510 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-1116-4559 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_422ddca2b8be7ab2367d2fe1ca7d014e
date	2021-05-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/34038639 https://doi.org/10.1021/acsinfecdis.1c00083
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/43689 https://portal.issn.org/resource/ISSN/2373-8227
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Quinoline and Quinazoline Derivatives Inhibit Viral RNA Synthesis by SARS-CoV-2 RdRp
discusses	http://id.nlm.nih.gov/mesh/M0019224 http://id.nlm.nih.gov/mesh/M0018350 http://id.nlm.nih.gov/mesh/M0018336 http://id.nlm.nih.gov/mesh/M0019157
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D000086402Q000187 http://id.nlm.nih.gov/mesh/D011804Q000494 http://id.nlm.nih.gov/mesh/D011799Q000494 http://id.nlm.nih.gov/mesh/D012324Q000037
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D012367Q000096
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7047 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9082 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6762 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9210

Total number of triples: 56.